03/05/2026
Missed it live? You can now watch the replay.
This past Sunday, our ALK Positive community gathered for an important ALKtALK conversation with thoracic oncologist Dr. Alex Drilon to explore the latest developments in ALK-targeted therapy research.
We’re now sharing the full recording on our YouTube channel so patients, caregivers, and advocates can access this information anytime.
In this session, Dr. Drilon discusses new data and emerging directions for neladalkib (NVL-655) and how precision oncology continues to shape the future of treatment for ALK-positive lung cancer. Conversations like this help translate complex research into clear information our community can understand and use when speaking with their care teams.
New Data, New Directions: Neladalkib (NVL-655) and Precision Oncology in ALK-Positive Lung Cancer
Press play to stay informed and empowered.
🎥 Watch the replay here:
https://youtu.be/PRrfLmIQb9I?si=294oYTXW_1xT86Rl